Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Lipid lowering in renal disease

Thumbnail Image

Date

2017

Authors

Kennard, Alice
Singer, Richard

Journal Title

Journal ISSN

Volume Title

Publisher

National Prescribing Service

Abstract

Statins reduce the risk of cardiovascular disease in patients with chronic kidney disease who do not require dialysis. However, this benefit diminishes with progression of kidney disease and in transplant recipients. Current evidence suggests that statins may not reduce cardiovascular risk in patients with advanced chronic kidney disease requiring dialysis. Evidence for fibrates is more limited but they appear to reduce lipids and cardiovascular events in patients with mild to moderate chronic kidney disease. There is little evidence for the benefit of starting statins in patients on haemodialysis.

Description

Keywords

Citation

URI

http://hdl.handle.net/1885/186636

Collections

ANU Research Publications

Source

Australian Prescriber

Type

Journal article

Book Title

Entity type

Access Statement

Open Access via publisher website

License Rights

DOI

10.18773/austprescr.2017.047

Restricted until

DSpace software copyright © 2002-2026 LYRASIS